InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Discover the full record of transactions filed by Nolet Chris. Director active across 1 companies, notably Revance Therapeutics, Inc.. In total, 3 disclosures have been published. The latest transaction was filed on 4 May 2022 — Attribution. Regulator: SEC (Form 4). All data is accessible without signup.
Declarations3 total
06,059 shares0
Common Stock
SEC:0001479290-22-000063:0·
04,013 shares0
Common Stock
SEC:0001479290-21-000112·
04,013 shares0
Common Stock
SEC:0001479290-21-000112:0·
3 of 3 declarations
